Yousefi B, Samadi N, Baradaran B, Rameshknia V, Shafiei-Irannejad V, Majidinia M, Targhaze N, Zarghami N. Differential effects of peroxisome proliferator-activated receptor agonists on doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells. Cell Mol Biol (Noisy-le-grand) [Internet]. 2015 Dec. 30 [cited 2024 Nov. 21];61(8):118-22. Available from: https://mail.cellmolbiol.org/index.php/CMB/article/view/768